Anthony W. Partridge

3.5k total citations · 2 hit papers
40 papers, 2.4k citations indexed

About

Anthony W. Partridge is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Anthony W. Partridge has authored 40 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Immunology and Allergy. Recurrent topics in Anthony W. Partridge's work include Lipid Membrane Structure and Behavior (8 papers), Ubiquitin and proteasome pathways (6 papers) and Chemical Synthesis and Analysis (6 papers). Anthony W. Partridge is often cited by papers focused on Lipid Membrane Structure and Behavior (8 papers), Ubiquitin and proteasome pathways (6 papers) and Chemical Synthesis and Analysis (6 papers). Anthony W. Partridge collaborates with scholars based in United States, Canada and Singapore. Anthony W. Partridge's co-authors include Mark H. Ginsberg, Charles M. Deber, Sanford J. Shattil, Roman A. Melnyk, Iain D. Campbell, Robert Liddington, Andrew R. Pickford, Jaewon Han, Kate L. Wegener and Alex G. Therien and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Anthony W. Partridge

40 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structural Basis of Integrin Activation by Talin

2007 522 citations Kate L. Wegener, Anthony W. Partridge et al. Cell profile →
Phase-separating peptides for direct cytosolic delivery and redox-activated release of macromolecular therapeutics

2022 276 citations Yue Sun, Sze Yi Lau et al. Nature Chemistry profile →

Peers

Countries citing papers authored by Anthony W. Partridge

Since Specialization

Citations

This map shows the geographic impact of Anthony W. Partridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony W. Partridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony W. Partridge more than expected).

Fields of papers citing papers by Anthony W. Partridge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony W. Partridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony W. Partridge. The network helps show where Anthony W. Partridge may publish in the future.

Co-authorship network of co-authors of Anthony W. Partridge

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony W. Partridge. A scholar is included among the top collaborators of Anthony W. Partridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony W. Partridge. Anthony W. Partridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular Mechanism of P53 Peptide Permeation through Lipid Membranes from Solid-State NMR Spectroscopy and Molecular Dynamics Simulations 2024 ·Journal of the American Chemical Society ·Mingyue Li, Jianguo Li, Xingyu Lu, (unknown), Arun Chandramohan, W. Peter Wuelfing, Allen C. Templeton, Wei Xu, Marian E. Gindy, Filippos Kesisoglou, Jing Ling, Tomi K. Sawyer, Chandra Verma, Anthony W. Partridge, Yongchao Su	3
2	MDM2/MDMX inhibition by Sulanemadlin synergizes with anti-Programmed Death 1 immunotherapy in wild-type p53 tumors 2024 ·iScience ·(unknown), Marit M. Melssen, Pavitra Kannan, Arun Chandramohan, Anthony W. Partridge, (unknown), (unknown), David P. Lane, Marika Nestor, Diana Spiegelberg	8
3	Phase-separating peptides for direct cytosolic delivery and redox-activated release of macromolecular therapeutics breakdown → 2022 ·Nature Chemistry ·Yue Sun, Sze Yi Lau, Zhi Wei Lim, (unknown), Farid J. Ghadessy, Anthony W. Partridge, Ali Miserez	276
4	Liposome Click Membrane Permeability Assay for Identifying Permeable Peptides 2021 ·Pharmaceutical Research ·Tanvi Desai, Bahanu Habulihaz, Joe R. Cannon, Arun Chandramohan, Hung Yi Kristal Kaan, (unknown), Tsz Ying Yuen, Charles W. Johannes, (unknown), (unknown), David P. Lane, Anthony W. Partridge, Raymond Evers, Tomi K. Sawyer, Jerome Hochman	9
5	bioPROTACs as versatile modulators of intracellular therapeutic targets including proliferating cell nuclear antigen (PCNA) 2020 ·Proceedings of the National Academy of Sciences ·Shuhui Lim, (unknown), (unknown), (unknown), Shih Chieh Chang, Simon Ng, Greg L. Beilhartz, Roman A. Melnyk, Charles W. Johannes, Christopher J. Brown, David P. Lane, Brian Henry, Anthony W. Partridge	107
6	Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles 2019 ·Chemical Science ·Tsz Ying Yuen, Christopher J. Brown, Yuezhen Xue, Yaw Sing Tan, (unknown), (unknown), (unknown), (unknown), Hung Yi Kristal Kaan, Anthony W. Partridge, Chandra Verma, David P. Lane, Charles W. Johannes	21
7	Repurposing a Histamine Detection Platform for High-Throughput Screening of Histidine Decarboxylase 2018 ·SLAS DISCOVERY ·Yu‐Chi Juang, Xavier Fradera, Yongxin Han, Anthony W. Partridge	2
8	Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes 2014 ·Scientific Reports ·Rodney K. Lyn, Ragunath Singaravelu, Stacia Kargman, (unknown), Helen M. Chan, Renata M. Oballa, Zheng Huang, Daniel M. Jones, Andrew Ridsdale, Rodney S. Russell, Anthony W. Partridge, John Paul Pezacki	55
9	An activity-based probe for high-throughput measurements of triacylglycerol lipases 2011 ·Analytical Biochemistry ·John Tam, Martin Hénault, Lianhai Li, Zhaoyin Wang, Anthony W. Partridge, Roman A. Melnyk	12
10	Resorufin Butyrate as a Soluble and Monomeric High-Throughput Substrate for a Triglyceride Lipase 2011 ·SLAS DISCOVERY ·Vincent Lam, Martin Hénault, Karine Khougaz, (unknown), Marc Ouellet, Roman A. Melnyk, Anthony W. Partridge	5
11	Structural Basis of Integrin Activation by Talin breakdown → 2007 ·Cell ·Kate L. Wegener, Anthony W. Partridge, Jaewon Han, Andrew R. Pickford, Robert Liddington, Mark H. Ginsberg, Iain D. Campbell	522
12	The antithrombotic potential of selective blockade of talin-dependent integrin αIIbβ3 (platelet GPIIb–IIIa) activation 2007 ·Journal of Clinical Investigation ·Brian G. Petrich, Per Fogelstrand, Anthony W. Partridge, (unknown), Ararat J. Ablooglu, Sanford J. Shattil, Mark H. Ginsberg	105
13	Self-association of the Transmembrane Domain of an Anthrax Toxin Receptor 2006 ·Journal of Molecular Biology ·(unknown), Sanguk Kim, Anthony W. Partridge, Roman A. Melnyk, Arianna Rath, Charles M. Deber, Jeremy Mogridge	21
14	Integrin activation by talin 2005 ·Journal of Thrombosis and Haemostasis ·Boris I. Ratnikov, Anthony W. Partridge, Mark H. Ginsberg	52
15	Transmembrane Domain Helix Packing Stabilizes Integrin αIIbβ3 in the Low Affinity State 2005 ·Journal of Biological Chemistry ·Anthony W. Partridge, Shouchun Liu, Sanguk Kim, James U. Bowie, Mark H. Ginsberg	117
16	Destabilization of the Transmembrane Domain Induces Misfolding in a Phenotypic Mutant of Cystic Fibrosis Transmembrane Conductance Regulator 2004 ·Journal of Biological Chemistry ·(unknown), Anthony W. Partridge, Craig Daniels, Kai Du, Gergely L. Lukács, Charles M. Deber	21
17	A Transmembrane Segment Mimic Derived from Escherichia coli Diacylglycerol Kinase Inhibits Protein Activity 2003 ·Journal of Biological Chemistry ·Anthony W. Partridge, Roman A. Melnyk, Dawn Yang, James U. Bowie, Charles M. Deber	36
18	Polar residue tagging of transmembrane peptides 2003 ·Biopolymers ·Roman A. Melnyk, Anthony W. Partridge, Jeannie Yip, Yanqiu Wu, Natalie K. Goto, Charles M. Deber	79
19	Transmembrane segment peptides with double D‐amino acid replacements: Helicity, hydrophobicity, and antimicrobial activity 2003 ·Biopolymers ·Mitsuko Maeda, Roman A. Melnyk, Anthony W. Partridge, Li‐Ping Liu, Charles M. Deber	8
20	Polar mutations in membrane proteins as a biophysical basis for disease 2002 ·Biopolymers ·Anthony W. Partridge, Alex G. Therien, Charles M. Deber	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact